// App-Quantinova.ai

4626 : In-vitro growth inhibitory effects of diosmetin on human prostate cancer cells

Researchers

Presenter

  • Rebecca Pakradooni

Principal Investigators

  • Riddhi Patel

  • Janmejai K. Srivastava

  • Sanjeev Shukla

Medical Centers

  • Case Western Reserve University, Cleveland, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

  • Solid malignancies

Biomarkers

  • AKT Serine

  • Cyclin dependent kinase inhibitor 1B

  • p70S6 kinase

  • cMYC

  • Insulin-like growth factor 1

  • Interleukin 6

  • Serine/threonine-protein kinase mTOR

  • X-linked inhibitor of apoptosis

Drug/Treatment

  • Rapacan

  • Androgen Tear

  • Mecasermin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved